Interact to see
Advertisement
Advertisement
MEDBX vs REBAX
MEDBX vs REBAX Comparison
Open Charts MEDBX vs REBAX
MFS Emerging Markets Debt B
Price$12.22
Change+$0.02 (+0.16%)
VolumeN/A
Net Assets7.3B
Columbia Emerging Markets Bond A
Price$9.68
Change+$0.02 (+0.21%)
VolumeN/A
Net Assets288.85M
MEDBX vs REBAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
MEDBX vs. REBAX commentary
Jul 22, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDBX is a Hold and REBAX is a Hold.
FUNDAMENTALS
Fundamentals
MEDBX has more cash in the bank: 7.3B vs. REBAX (289M). MEDBX (5.06) and REBAX (5.03) have matching dividends . MEDBX was incepted earlier than REBAX: MEDBX (23 years) vs REBAX (19 years). MEDBX (1.82) is less costly to investors than REBAX (1.13). MEDBX is a more actively managed with annual turnover of: 58.00 vs. REBAX (41.00). MEDBX has a lower initial minimum investment than REBAX: MEDBX (1000) vs REBAX (2000). REBAX annual gain was more profitable for investors over the last year : 7.67 vs. MEDBX (6.75). REBAX return over 5 years is better than : 8.79 vs. MEDBX (5.66).
| MEDBX | REBAX | MEDBX / REBAX | |
| Total Expense Ratio | 1.81 | 1.13 | 160% |
| Annual Report Gross Expense Ratio | 1.82 | 1.13 | 161% |
| Fund Existence | 23 years | 19 years | - |
| Gain YTD | 3.917 | 4.964 | 79% |
| Front Load | N/A | 5% | - |
| Min. Initial Investment | 1000 | 2000 | 50% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.3B | 289M | 2,525% |
| Annual Yield % from dividends | 5.06 | 5.03 | 101% |
| Returns for 1 year | 6.75 | 7.67 | 88% |
| Returns for 3 years | 28.67 | 29.64 | 97% |
| Returns for 5 years | 5.66 | 8.79 | 64% |
| Returns for 10 years | 27.32 | 34.84 | 78% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement